Harm reduction and emergency medical services: Opportunities for evidence-based programming.

Area of Science:

• Public Health
• Emergency Medicine
• Toxicology

Background:

• Overdose fatalities are increasingly linked to synthetic opioids like fentanyl.
• Xylazine, an animal tranquilizer, is now found in adulterated illicit substances, posing new risks.
• Drug testing services, including test strips, are evidence-based harm reduction tools.

Purpose of the Study:

• To advocate for the distribution of fentanyl and xylazine test strips by emergency medical services (EMS).
• To highlight the critical role of EMS in addressing the opioid epidemic.
• To examine potential barriers to implementing test strip distribution in EMS.

Main Methods:

• Literature review on synthetic opioid and xylazine adulteration.
• Analysis of the role of frontline healthcare providers in harm reduction.
• Critical evaluation of legal and logistical challenges for EMS implementation.

Main Results:

• Fentanyl and xylazine test strips can significantly reduce overdose risks.
• EMS are strategically positioned to distribute these vital harm reduction tools.
• Legal and other barriers may impede widespread adoption but can be addressed.

Conclusions:

• Distribution of fentanyl and xylazine test strips by EMS is a crucial harm reduction strategy.
• Overcoming implementation barriers is essential for saving lives.
• EMS can play a pivotal role in mitigating overdose fatalities.